Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Charchaflieh J, Rushbrook J, Worah S, Zhang M. Activated complement factors as disease markers for sepsis. Dis Markers.2015;2015:407324.
   Google Scholar
• Markiewski MM, DeAngelis RA, Lambris JD. Complexity of complement activation in sepsis. J Cell Mol Med. 2008;12(6A(6a):2245–2254. doi:10.1111/j.1582-4934.2008.00504.x
   Google Scholar
• Li H, Chen J, Hu Y, Cai X, Zhang P. et al. Elevated serum C1q levelsin children with sepsis. Front Ped. 2021;9(324):619899.   
   Google Scholar
• De Pascale G, Cutuli SL, Pennisi MA, et al. The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm. 2013;2013:625803. doi:10.1155/2013/625803
   Google Scholar
• Lin RY, Astiz ME, Saxon JC, et al. Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol. 1993;69(2):136–142. doi:10.1006/clin.1993.1161
   PubMedGoogle Scholar
• Charchaflieh J, Wei J, Labaze G, et al. The role of complement system in septic shock. Clin Dev Immunol. 2012;2012:407324. doi:10.1155/2012/407324
   PubMedGoogle Scholar
• Nakae H, Endo S, Inada K, et al. Chronological changes in the complement system in sepsis. Surg Today. 1996;26(4):225–229. doi:10.1007/BF00311579
   PubMed Web of Science ®Google Scholar
• Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133–142. doi:10.1038/nri1269
   PubMed Web of Science ®Google Scholar
• Tegla CA, Cudrici C, Patel S, et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45–60. doi:10.1007/s12026-011-8239-5
   PubMed Web of Science ®Google Scholar
• Dobrina A, Pausa M, Fischetti F, et al. Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood. 2002;99(1):185–192. doi:10.1182/blood.V99.1.185
   PubMed Web of Science ®Google Scholar
• Schuerholz T, Leuwer M, Cobas-Meyer M, et al. Terminal complement complex in septic shock with capillary leakage: marker of complement activation? Eur J Anaesthesiol. 2005;22(7):541–547. doi:10.1017/S0265021505000931
   PubMed Web of Science ®Google Scholar
• Zipfel PF, Skerka CJNRI. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9(10):729–740. doi:10.1038/nri2620
   PubMed Web of Science ®Google Scholar
• Liszewski MK, Atkinson JPJ; The American Society of Hematology Education Program Book. Too much of a good thing at the site of tissue injury: the instructive example of the complement system predisposing to thrombotic microangiopathy. Hematol Am Soc Hematol Educ Prog Book. 2011;2011(1):9–14. doi:10.1182/asheducation-2011.1.9
   PubMed Web of Science ®Google Scholar
• Meri S, Morgan BP, Davies A, et al. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology. 1990;71(1):1.
   PubMed Web of Science ®Google Scholar
• Meri S, Lehto T, Sutton CW, et al. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J. 1996;316(3):923–935. doi:10.1042/bj3160923
   PubMed Web of Science ®Google Scholar
• Ekdahl KN, Persson B, Mohlin C, et al. Interpretation of serological complement biomarkers in disease. Front Immunol. 2018;9:2237. doi:10.3389/fimmu.2018.02237
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Huber-Lang M. Complement in sepsis—when science meets clinics. FEBS Lett. 2020;594(16):2621–2632. doi:10.1002/1873-3468.13881
   PubMed Web of Science ®Google Scholar
• Peate I, Wild K. Nursing Practice: Knowledge and Care. John Wiley & Sons; 2018.
   Google Scholar
• Jarczak D, Kluge S, Nierhaus A. Sepsis—pathophysiology and therapeutic concepts. Front Med. 2021;8(609). doi:10.3389/fmed.2021.628302
   Web of Science ®Google Scholar
• Ward PA, Guo R-F, Riedemann NC. Manipulation of the complement system for benefit in sepsis. Crit Care Res Pract. 2012;2012:427607. doi:10.1155/2012/427607
   PubMedGoogle Scholar
• Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800. doi:10.1097/00003246-199811000-00016
   PubMed Web of Science ®Google Scholar
• Keshari RS, Silasi R, Popescu NI, et al. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc Natl Acad Sci U S A. 2017;114(31):E6390–E6399. doi:10.1073/pnas.1706818114
   PubMed Web of Science ®Google Scholar
• Guo RF, Ward PA. C5a, a therapeutic target in sepsis. Recent Pat Antiinfect Drug Discov. 2006;1(1):57–65. doi:10.2174/157489106775244091
   PubMedGoogle Scholar
• Abe T, Kubo K, Izumoto S, et al. Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation. Shock. 2020;54(2):198–204. doi:10.1097/SHK.0000000000001504
   PubMed Web of Science ®Google Scholar
• Parsons PE, Giclas PC. The Terminal Complement Complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome. Am Rev Respir Dis. 1990;141(1):98–103. doi:10.1164/ajrccm/141.1.98
   PubMed Web of Science ®Google Scholar
• Müller GA. The release of glycosylphosphatidylinositol-anchored proteins from the cell surface. Arch Biochem Biophys. 2018;656:1–18. doi:10.1016/j.abb.2018.08.009
   PubMed Web of Science ®Google Scholar
• Murao A, Brenner M, Aziz M, et al. Exosomes in Sepsis. Front Immunol. 2020;11:2140. doi:10.3389/fimmu.2020.02140
   PubMed Web of Science ®Google Scholar
• Lindström O, Jarva H, Meri S, et al. Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis. Scand J Gastroenterol. 2008;43(3):350–355. doi:10.1080/00365520701763209
   PubMed Web of Science ®Google Scholar
• Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2):132–144. doi:10.1159/000085265
   PubMed Web of Science ®Google Scholar
• Väkevä A, Lehto T, Takala A, et al. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction. Scand J Immunol. 2000;52(4):411–414. doi:10.1046/j.1365-3083.2000.00783.x
   PubMed Web of Science ®Google Scholar
• Ohtani K. Complement-related proteins and their measurements: the current status of clinical investigation. Nephron. 2020;144(suppl 1):7–12. doi:10.1159/000512494
   PubMed Web of Science ®Google Scholar